Home Federal Bank Of Tennessee Amgen Inc Transaction History

Home Federal Bank Of Tennessee

  • $322 Million
  • Q1 2024

A detailed history of Home Federal Bank Of Tennessee transactions in Amgen Inc stock. As of the latest transaction made, Home Federal Bank Of Tennessee holds 2,253 shares of AMGN stock, worth $711,745. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,253
Previous 2,271 0.79%
Holding current value
$711,745
Previous $654,000 2.14%
% of portfolio
0.2%
Previous 0.22%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024
SELL
$268.87 - $324.56 $4,839 - $5,842
-18 Reduced 0.79%
2,253 $640,000
Q4 2023

Jan 18, 2024
SELL
$255.7 - $288.46 $1,789 - $2,019
-7 Reduced 0.31%
2,271 $654,000
Q3 2023

Oct 23, 2023
SELL
$218.65 - $271.46 $26,675 - $33,118
-122 Reduced 5.08%
2,278 $612,000
Q2 2023

Jul 18, 2023
SELL
$214.27 - $253.37 $10,713 - $12,668
-50 Reduced 2.04%
2,400 $532,000
Q1 2023

Apr 14, 2023
BUY
$225.79 - $275.2 $3,386 - $4,128
15 Added 0.62%
2,450 $592,000
Q4 2022

Jan 19, 2023
BUY
$229.03 - $291.01 $68,709 - $87,303
300 Added 14.05%
2,435 $0
Q2 2022

Jul 15, 2022
BUY
$230.71 - $256.74 $19,610 - $21,822
85 Added 4.15%
2,135 $519,000
Q1 2022

Apr 12, 2022
BUY
$219.27 - $242.57 $32,890 - $36,385
150 Added 7.89%
2,050 $496,000
Q4 2021

Jan 12, 2022
BUY
$198.88 - $227.6 $83,529 - $95,592
420 Added 28.38%
1,900 $428,000
Q3 2021

Oct 13, 2021
BUY
$212.27 - $248.7 $35,024 - $41,035
165 Added 12.55%
1,480 $314,000
Q2 2021

Jul 13, 2021
BUY
$233.58 - $259.14 $307,157 - $340,769
1,315 New
1,315 $320,000

Others Institutions Holding AMGN

# of Institutions
2,936
Shares Held
401M
Call Options Held
6.59M
Put Options Held
6.6M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Home Federal Bank Of Tennessee Portfolio

Follow Home Federal Bank Of Tennessee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Home Federal Bank Of Tennessee, based on Form 13F filings with the SEC.

News

Stay updated on Home Federal Bank Of Tennessee with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email